Atlas Trials

Loreline Study: Characterization of Long Responders Under Eribuline

Clinical trial NCT03771183 · COMPLETED

Trial details

NCT number
NCT03771183
Sponsor
Centre Jean Perrin
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer PatientsTherapy Related Tumor
Start date
2019-08-23
Primary completion
2020-11-30
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.